Healthcare provider profile · identity verified

Chiapone David Ting, MD

Internal Medicine · HALLANDALE BEACH, FL · NPI 1265479315

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Alprazolam	Alprazolam	320	64
Atorvastatin Calcium	Atorvastatin Calcium	259	110
Zolpidem Tartrate	Zolpidem Tartrate	211	33
Metformin Hcl	Metformin Hcl	198	77
Amlodipine Besylate	Amlodipine Besylate	184	69
Levothyroxine Sodium	Levothyroxine Sodium	177	69
Temazepam	Temazepam	175	23
Rosuvastatin Calcium	Rosuvastatin Calcium	169	64
Lisinopril	Lisinopril	164	68
Omeprazole	Omeprazole	151	68
Lorazepam	Lorazepam	125	25
Losartan Potassium	Losartan Potassium	111	41
Meloxicam	Meloxicam	102	50
Simvastatin	Simvastatin	86	34
Tamsulosin Hcl	Tamsulosin Hcl	82	37
Alendronate Sodium	Alendronate Sodium	78	28
Hydrochlorothiazide	Hydrochlorothiazide	76	33
Metoprolol Succinate	Metoprolol Succinate	74	31
Diazepam	Diazepam	69	15
Albuterol Sulfate Hfa	Albuterol Sulfate	66	42
Furosemide	Furosemide	63	32
Januvia	Sitagliptin Phosphate	54	17
Metoprolol Tartrate	Metoprolol Tartrate	54	22
Glimepiride	Glimepiride	53	20
Fluticasone Propionate	Fluticasone Propionate	48	17
Jardiance	Empagliflozin	48	20
Gabapentin	Gabapentin	46	28
Donepezil Hcl	Donepezil Hcl	45	19
Nifedipine Er	Nifedipine	45	17
Pantoprazole Sodium	Pantoprazole Sodium	43	21
Clopidogrel	Clopidogrel Bisulfate	42	17
Methylprednisolone	Methylprednisolone	40	37
Baclofen	Baclofen	38	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	11
Azithromycin	Azithromycin	31	29
Allopurinol	Allopurinol	30	suppressed
Carvedilol	Carvedilol	30	16
Sildenafil Citrate	Sildenafil Citrate	30	14
Amoxicillin	Amoxicillin	28	21
Meclizine Hcl	Meclizine Hcl	28	15
Terbinafine Hcl	Terbinafine Hcl	28	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	27	suppressed
Ibuprofen	Ibuprofen	27	17
Clonidine Hcl	Clonidine Hcl	26	suppressed
Ezetimibe	Ezetimibe	26	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	24
Sertraline Hcl	Sertraline Hcl	26	suppressed
Celecoxib	Celecoxib	25	14
Tramadol Hcl	Tramadol Hcl	24	20
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	15
Diclofenac Sodium	Diclofenac Sodium	23	13
Latanoprost	Latanoprost	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	21
Eliquis	Apixaban	22	12
Escitalopram Oxalate	Escitalopram Oxalate	22	11
Finasteride	Finasteride	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	17
Famotidine	Famotidine	19	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Atenolol	Atenolol	18	suppressed
Ozempic	Semaglutide	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	15
Clonazepam	Clonazepam	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	12
Glipizide	Glipizide	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Trazodone Hcl	Trazodone Hcl	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Mometasone Furoate	Mometasone Furoate	15	14
Montelukast Sodium	Montelukast Sodium	15	suppressed
Ramipril	Ramipril	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Lovastatin	Lovastatin	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error